Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone Iodine and Glycyrrhizin for VAP Prevention
NCT05895773Phase 3Completed
- Sponsor
- Menoufia University
- Start
- Jun 2023
- Primary completion
- Nov 2023
- Modality
- Nucleic Acid-Directed Small Molecules, Hydrogel Systems, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of IVIEW-1502, glycyrrhizin in ventilator-associated pneumonia (VAP), ventilator-associated tracheobronchitis (VAT), sponsored by Menoufia University. Started Jun 2023; status: completed.
02
Drugs
IVIEW-1502glycyrrhizin
03
Conditions
ventilator-associated pneumonia (VAP)ventilator-associated tracheobronchitis (VAT)
Beyond the preview
Go deeper on NCT05895773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05895773.